XML 28 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
10. Stock-based Compensation
6 Months Ended
Mar. 31, 2017
Share-based Compensation [Abstract]  
Stock-based Compensation

From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period.

 

Stock Options

 

The following table summarizes stock option activity for the six months ended March 31, 2017:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life   Intrinsic Value 
Outstanding at September 30, 2016   175,000   $11.22    3.75   $346,500 
Granted   36,668    22.52           
Exercised                   
Forfeited                   
Outstanding at March 31, 2017   211,668   $13.19    3.98   $899,875 
Exercisable at March 31, 2017   168,750   $8.85    2.54   $899,875 

 

The Company recognized compensation expense of $69,520 and $174,885 during the six months ended March 31, 2017 and 2016, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures.

 

At March 31, 2017 the Company has $495,796 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the company expects to recognize as compensation expense through December of 2021.

  

The exercise price for stock options outstanding and exercisable at March 31, 2017 is as follows:

 

Outstanding   Exercisable 
Number of   Exercise   Number of   Exercise 
Options   Price   Options   Price 
 31,250   $5.00    31,250   $5.00 
 25,000    7.50    25,000    7.50 
 31,250    10.00    31,250    10.00 
 4,167    10.86           
 4,167    10.86           
 4,167    10.86           
 4,167    10.86           
 6,250    12.50    6,250    12.50 
 6,250    15.00        15.00 
 75,000    15.18    75,000    15.18 
 4,000    23.41           
 4,000    27.60           
 4,000    31.74           
 4,000    36.50           
 4,000    41.98           
 211,668         168,750      

 

The following table summarizes information about the Company’s non-vested shares as of March 31, 2017:

 

Non-vested Shares     Number of Shares       Weighted Average Grant-Date Fair Value  
                 
Non-vested at September 30, 2016     6,250     $ 14.22  
Granted     36,668     $ 17.70  
Vested     –           
Non-vested at March 31, 2017     42,918     $ 17.19  

 

Options were granted during 2017 and 2016, where the exercise price was less than the common stock price at the date of grant or where the exercise price was greater than the common stock price at the date of grant. The assumptions used in calculating the fair value of stock options granted use the Black-Scholes option pricing model for options granted were as follows:

 

Risk-free interest rate   1.25%
Expected life of the options   5.0 to 10.0 years
Expected volatility   107%
Expected dividend yield   0%